Carlsmed (CARL) vs Embecta (EMBC)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Carlsmed (CARL) has outperformed Embecta (EMBC) over the past year, gaining 5.8% versus a loss of 57.1%. Carlsmed is the larger company by market cap ($392.6 million vs $334.9 million), about 1.2 times the size. Embecta pays a dividend yielding 7.78%, while Carlsmed does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CARL | EMBC |
|---|---|---|
| Share price | $14.38 | $5.91 |
| Market cap | $392.61M | $334.86M |
| 1-day change | -1.78% | -0.67% |
| YTD return | +16.44% | -50.25% |
| 1-year return | +5.81% | -57.11% |
| P/E ratio (TTM) | — | 4.02 |
| Forward P/E | — | 3.35 |
| EPS (TTM) | $-1.08 | $1.47 |
| Dividend yield | 0.00% | 7.78% |
| Annual dividend | $0.00 | $0.46 |
| 52-week high | $17.23 | $14.91 |
| 52-week low | $8.50 | $2.77 |
| Distance from 52-week high | -16.54% | -60.36% |
| Average volume | 127.70K | 1.38M |
| Shares outstanding | 27.30M | 56.66M |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- CARL has outperformed EMBC by 62.9 percentage points over the past year.
- Embecta offers a meaningfully higher dividend yield (7.78% vs 0.00%).
CARL vs EMBC FAQ
Which is bigger, Carlsmed or Embecta?
Carlsmed (CARL) is larger, with a market capitalization of $392.61M compared with $334.86M for Embecta (EMBC).
Which stock has performed better over the past year, CARL or EMBC?
CARL returned +5.81% over the past 12 months, compared with -57.11% for EMBC (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, Carlsmed or Embecta?
Embecta pays a dividend yielding 7.78%, while Carlsmed does not currently pay a regular dividend.
Are Carlsmed and Embecta in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.